ACC1 loss in ESCC promotes metastasis by enhancing histone acetylation and activating c-Fos/CXCL8, driving EMT, neutrophil recruitment, and NET formation, highlighting the ACC1–CXCL8–NET axis as a prognostic and therapeutic target.
- Jiaping Tang
- Bo Qi
- Baosheng Zhao